Document Detail


Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Heart Disease and Diabetes Risk Indicators in a Screened Cohort.
MedLine Citation:
PMID:  9484985     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Syndromes of risk factor disturbance may contribute to the development of coronary heart disease and non-insulin-dependent diabetes mellitus, but their definition and quantification remain problematic. Using factor analysis, constellations of risk factor variables that could indicate distinct syndromes of metabolic disturbance were explored in the baseline data of the first follow-up cohort of 742 men from the Heart Disease and Diabetes Risk Indicators in a Screened Cohort (HDDRISC) study. The primary analysis considered 16 intercorrelated variables measured in more than 90% of cohort participants. A missing-values estimation routine was used to ensure inclusion of all participants in the analysis. Subanalyses were undertaken, including a repeat of the primary analysis on the 522 individuals who had received measurement of HDL cholesterol, an oblique rather than orthogonal factor rotation procedure performed on primary and HDL subset analyses, a repeat of these two primary and HDL subset analyses using only those participants with complete measurements, and a repeat of these six analyses including only the seven variables conventionally associated with the metabolic syndrome. The principal factor that emerged in all analyses undertaken comprised oral glucose tolerance test insulin and glucose response, serum uric acid, and body mass index. Fasting serum triglyceride concentration was included in this factor in 11 of the 12 analyses undertaken, fasting plasma insulin in 8, fasting plasma glucose in 5, and mean arterial pressure in 3. HDL cholesterol factored in isolation from insulin in all analyses undertaken. These findings provide strong support for a core metabolic cluster, which is unlikely to include blood pressure and does not include HDL. The factor scores relating to this cluster will provide a means of assessing its quantitative importance in prospective analysis of the development of CHD and diabetes in this cohort.
Authors:
F Leyva; I F Godsland; M Worthington; C Walton; J C Stevenson
Related Documents :
18758745 - Downregulation of genes involved in nfkappab activation in peripheral blood mononuclear...
20616745 - The right fiber for the right disease: an update on the psyllium seed husk and the meta...
21194385 - Cortical neurons develop insulin resistance and blunted akt signaling: a potential mech...
15458765 - Emerging aspects of pharmacotherapy for obesity and metabolic syndrome.
12950465 - Evidence for an active transport of morphine-6-beta-d-glucuronide but not p-glycoprotei...
25136065 - Albiglutide: a new glp-1 receptor agonist for the treatment of type 2 diabetes.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  18     ISSN:  1079-5642     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-03-19     Completed Date:  1998-03-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  208-14     Citation Subset:  IM    
Affiliation:
Wynn Department of Metabolic Medicine, Imperial College School of Medicine, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Glucose / analysis
Cholesterol, HDL / blood
Cohort Studies
Diabetes Mellitus / etiology*
Factor Analysis, Statistical
Follow-Up Studies
Glucose Tolerance Test
Heart Diseases / etiology*
Humans
Insulin / blood
Male
Metabolic Diseases / blood,  complications*
Middle Aged
Prospective Studies
Risk Factors
Syndrome
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Cholesterol, HDL; 11061-68-0/Insulin
Comments/Corrections
Erratum In:
Arterioscler Thromb Vasc Biol 1998 Jul;18(7):1198

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombo...
Next Document:  Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene ...